Details for New Drug Application (NDA): 213441
✉ Email this page to a colleague
The generic ingredient in NORTRIPTYLINE HYDROCHLORIDE is nortriptyline hydrochloride. There are twelve drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
Summary for 213441
Tradename: | NORTRIPTYLINE HYDROCHLORIDE |
Applicant: | Zydus Lifesciences |
Ingredient: | nortriptyline hydrochloride |
Patents: | 0 |
Suppliers and Packaging for NDA: 213441
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 213441 | ANDA | Zydus Pharmaceuticals (USA) Inc. | 70710-1153 | 70710-1153-1 | 100 CAPSULE in 1 BOTTLE (70710-1153-1) |
NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 213441 | ANDA | Zydus Pharmaceuticals (USA) Inc. | 70710-1153 | 70710-1153-3 | 30 CAPSULE in 1 BOTTLE (70710-1153-3) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Feb 24, 2021 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Feb 24, 2021 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Feb 24, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription